Therapy
Biotechnology
Health

Intellia Therapeutics

4,317

$13.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.41 (-2.94%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours

Why Robinhood?

You can buy or sell NTLA and other stocks, options, ETFs, and crypto commission-free!

About NTLA

Intellia Therapeutics, Inc. engages in the development of gene editing-based therapies. It provides scientific expertise, clinical development, and intellectual property position to unlock broad therapeutic applications of CRISPR or Cas9 genome editing and develop a potential new drug class. Read More The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

CEO
John M. Leonard
Employees
211
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
681.42M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
704.09K
High Today
$14.21
Low Today
$13.23
Open Price
$13.94
Volume
561.75K
52 Week High
$19.00
52 Week Low
$10.26

Collections

Therapy
Biotechnology
Health
Medical
Technology
2016 IPO
US
North America

NTLA News

ReutersNov 9

Edited Transcript of NTLA earnings conference call or presentation 31-Oct-19 12:00pm GMT

Q3 2019 Intellia Therapeutics Inc Earnings Call CAMBRIDGE Nov 10, 2019 (Thomson StreetEvents) -- Edited Transcript of Intellia Therapeutics Inc earnings confer
9

NTLA Earnings

-$0.60
-$0.54
-$0.49
-$0.43
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
-$0.49 per share
Replay Earnings Call

You May Also Like

IPI
AG
PSA-V
FXD
ACAD
RPUT
HCXZ
NCV
SSY
PZZA
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy NTLA

Market Price$13.53
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell NTLA stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up